Year: 2020

Notes on Criminal Economics

Ross Eventon* In a recent report for GDPO, I discussed the links between national economic models and illicit cultivation, and the way this important context has been largely ignored by the drug policy community; localised projects – amounting to rural development aid – have instead been the focus of attention. In this blog I would…Continue Reading Notes on Criminal Economics

Trump v Biden. Their stances on Drug Policy: ‘How it started. How it’s going.’

Branwen Lloyd* The 2020 United States presidential election—with early voting underway and Election Day on November 3—is already like no other in history. In a pivotal year the presidential campaign has been repeatedly shaken by seismic events: a devastating pandemic, George Floyd’s killing by police officers, and subsequent protests, President Donald Trump contracting COVID-19, and…Continue Reading Trump v Biden. Their stances on Drug Policy: ‘How it started. How it’s going.’

Cultivating Change: The Contemporary Challenges of Studying Cannabis Regulation in Jamaica

Branwen Lloyd* At the end of summer 2019 the GDPO was successful in an application to Swansea University’s Higher Education Funding Council for Wales – Global Challenges Research Fund (GCRF) scheme. The GCRF is a £1.5 billion fund announced by the UK Government in 2015 to support cutting-edge research that addresses the challenges faced by…Continue Reading Cultivating Change: The Contemporary Challenges of Studying Cannabis Regulation in Jamaica

Drugs, Prisons and ‘Unintended Consequences’ – Does drug interdiction drive drug-related harms?

Rick Lines, Olivia Howells and Daniel Webb* The availability of drugs in prisons around the world is well documented. In Europe alone, up to seventy percent of people in prison have used an illicit drug. In Canada, forty-eight percent of prisoners in federal correctional institutions have had ‘problems’ with drugs. In Australia, one in six…Continue Reading Drugs, Prisons and ‘Unintended Consequences’ – Does drug interdiction drive drug-related harms?